Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mylan Grabs More FDA Globalization Talent

This article was originally published in The Pink Sheet Daily

Executive Summary

Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.

You may also be interested in...



After Recusal, Schnedar Leaving CDER Compliance Office

Cynthia Schnedar decides to leave several weeks after FDA determined that her husband's promotion could create conflicts of interest.

FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss

While Mylan wants Autor to help push quality improvement efforts around the world, her departure from FDA may affect implementation of similar plans at the agency.

Drug Shortages Give Ben Venue Relief In FDA Consent Decree

The consent decree permits the company to continue to manufacture more than 100 drugs, 20 of which are on FDA’s current drug shortage list. Ben Venue must prove compliance with good manufacturing practice requirements before it can manufacture its other drugs.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS077141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel